Literature DB >> 10022907

Impaired translesion synthesis in xeroderma pigmentosum variant extracts.

A M Cordonnier1, A R Lehmann, R P Fuchs.   

Abstract

Xeroderma pigmentosum variant (XPV) cells are characterized by a cellular defect in the ability to synthesize intact daughter DNA strands on damaged templates. Molecular mechanisms that facilitate replication fork progression on damaged DNA in normal cells are not well defined. In this study, we used single-stranded plasmid molecules containing a single N-2-acetylaminofluorene (AAF) adduct to analyze translesion synthesis (TLS) catalyzed by extracts of either normal or XPV primary skin fibroblasts. In one of the substrates, the single AAF adduct was located at the 3' end of a run of three guanines that was previously shown to induce deletion of one G by a slippage mechanism. Primer extension reactions performed by normal cellular extracts from four different individuals produced the same distinct pattern of TLS, with over 80% of the products resulting from the elongation of a slipped intermediate and the remaining 20% resulting from a nonslipped intermediate. In contrast, with cellular extracts from five different XPV patients, the TLS reaction was strongly reduced, yielding only low amounts of TLS via the nonslipped intermediate. With our second substrate, in which the AAF adduct was located at the first G in the run, thus preventing slippage from occurring, we confirmed that normal extracts were able to perform TLS 10-fold more efficiently than XPV extracts. These data demonstrate unequivocally that the defect in XPV cells resides in translesion synthesis independently of the slippage process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022907      PMCID: PMC84013          DOI: 10.1128/MCB.19.3.2206

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Involvement of the yeast DNA polymerase delta in DNA repair in vivo.

Authors:  L Giot; R Chanet; M Simon; C Facca; G Faye
Journal:  Genetics       Date:  1997-08       Impact factor: 4.562

2.  Thymine-thymine dimer bypass by yeast DNA polymerase zeta.

Authors:  J R Nelson; C W Lawrence; D C Hinkle
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

3.  New strategy for the construction of single-stranded plasmids with single mutagenic lesions.

Authors:  R L Napolitano; R P Fuchs
Journal:  Chem Res Toxicol       Date:  1997-06       Impact factor: 3.739

4.  Replication fork bypass of a pyrimidine dimer blocking leading strand DNA synthesis.

Authors:  M Cordeiro-Stone; L S Zaritskaya; L K Price; W K Kaufmann
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

5.  Mechanisms of frameshift mutations: insight from aromatic amines.

Authors:  G R Hoffmann; R P Fuchs
Journal:  Chem Res Toxicol       Date:  1997-04       Impact factor: 3.739

6.  Bypass of a site-specific cis-Syn thymine dimer in an SV40 vector during in vitro replication by HeLa and XPV cell-free extracts.

Authors:  I Ensch-Simon; P M Burgers; J S Taylor
Journal:  Biochemistry       Date:  1998-06-02       Impact factor: 3.162

7.  Proliferating cell nuclear antigen promotes DNA synthesis past template lesions by mammalian DNA polymerase delta.

Authors:  D J Mozzherin; S Shibutani; C K Tan; K M Downey; P A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

8.  Analysis of damage tolerance pathways in Saccharomyces cerevisiae: a requirement for Rev3 DNA polymerase in translesion synthesis.

Authors:  K Baynton; A Bresson-Roy; R P Fuchs
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

9.  Deoxycytidyl transferase activity of yeast REV1 protein.

Authors:  J R Nelson; C W Lawrence; D C Hinkle
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

Review 10.  DNA polymerase zeta and the control of DNA damage induced mutagenesis in eukaryotes.

Authors:  C W Lawrence; D C Hinkle
Journal:  Cancer Surv       Date:  1996
View more
  21 in total

1.  Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.

Authors:  C Masutani; M Araki; A Yamada; R Kusumoto; T Nogimori; T Maekawa; S Iwai; F Hanaoka
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells.

Authors:  P Kannouche; B C Broughton; M Volker; F Hanaoka; L H Mullenders; A R Lehmann
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

3.  Polymerase eta deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair.

Authors:  C L Limoli; E Giedzinski; W F Morgan; J E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 4.  DNA polymerase iota and related rad30-like enzymes.

Authors:  J P McDonald; A Tissier; E G Frank; S Iwai; F Hanaoka; R Woodgate
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

5.  Mechanisms of accurate translesion synthesis by human DNA polymerase eta.

Authors:  C Masutani; R Kusumoto; S Iwai; F Hanaoka
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

6.  Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa.

Authors:  E Ohashi; T Ogi; R Kusumoto; S Iwai; C Masutani; F Hanaoka; H Ohmori
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

7.  Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase iota.

Authors:  A Tissier; E G Frank; J P McDonald; S Iwai; F Hanaoka; R Woodgate
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

8.  Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Authors:  Hiroki Inui; Kyu-Seon Oh; Carine Nadem; Takahiro Ueda; Sikandar G Khan; Ahmet Metin; Engin Gozukara; Steffen Emmert; Hanoch Slor; David B Busch; Carl C Baker; John J DiGiovanna; Deborah Tamura; Cornelia S Seitz; Alexei Gratchev; Wen Hao Wu; Kee Yang Chung; Hye Jin Chung; Esther Azizi; Roger Woodgate; Thomas D Schneider; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

9.  Effect of cross-link structure on DNA interstrand cross-link repair synthesis.

Authors:  Michael B Smeaton; Erica M Hlavin; Anne M Noronha; Sebastian P Murphy; Christopher J Wilds; Paul S Miller
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

10.  Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks.

Authors:  Akira Motegi; Hung-Jiun Liaw; Kyoo-Young Lee; Henk P Roest; Alex Maas; Xiaoli Wu; Helen Moinova; Sanford D Markowitz; Hao Ding; Jan H J Hoeijmakers; Kyungjae Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.